These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Novel camphane-based anti-tuberculosis agents with nanomolar activity. Stavrakov G; Valcheva V; Philipova I; Doytchinova I Eur J Med Chem; 2013; 70():372-9. PubMed ID: 24177364 [TBL] [Abstract][Full Text] [Related]
8. Syntheses of lipophilic chalcones and their conformationally restricted analogues as antitubercular agents. Ahmad I; Thakur JP; Chanda D; Saikia D; Khan F; Dixit S; Kumar A; Konwar R; Negi AS; Gupta A Bioorg Med Chem Lett; 2013 Mar; 23(5):1322-5. PubMed ID: 23369537 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and in vitro antimycobacterial activity of compounds derived from (R)- and (S)-2-amino-1-butanol - The crucial role of the configuration. Dobrikov GM; Valcheva V; Stoilova-Disheva M; Momekov G; Tzvetkova P; Chimov A; Dimitrov V Eur J Med Chem; 2012 Feb; 48():45-56. PubMed ID: 22154833 [TBL] [Abstract][Full Text] [Related]
10. Rational design and synthesis of novel dibenzo[b,d]furan-1,2,3-triazole conjugates as potent inhibitors of Mycobacterium tuberculosis. Yempala T; Sridevi JP; Yogeeswari P; Sriram D; Kantevari S Eur J Med Chem; 2014 Jan; 71():160-7. PubMed ID: 24292337 [TBL] [Abstract][Full Text] [Related]
11. Antimycobacterial activity of diphenylpyraline derivatives. Weis R; Faist J; di Vora U; Schweiger K; Brandner B; Kungl AJ; Seebacher W Eur J Med Chem; 2008 Apr; 43(4):872-9. PubMed ID: 17714832 [TBL] [Abstract][Full Text] [Related]
12. Rational design, synthesis and antitubercular evaluation of novel 2-(trifluoromethyl)phenothiazine-[1,2,3]triazole hybrids. Addla D; Jallapally A; Gurram D; Yogeeswari P; Sriram D; Kantevari S Bioorg Med Chem Lett; 2014 Jan; 24(1):233-6. PubMed ID: 24314670 [TBL] [Abstract][Full Text] [Related]
13. Novel amide and sulphonamide derivatives of 6-(piperazin-1-yl)phenanthridine as potent Mycobacterium tuberculosis H37Rv inhibitors. Naidu KM; Nagesh HN; Singh M; Sriram D; Yogeeswari P; Gowri Chandra Sekhar KV Eur J Med Chem; 2015 Mar; 92():415-26. PubMed ID: 25590862 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of substituted 4,6-diarylpyrimidines and 3,5-diphenyl-4,5-dihydro-1H-pyrazoles as anti-tubercular agents. Pathak V; Maurya HK; Sharma S; Srivastava KK; Gupta A Bioorg Med Chem Lett; 2014 Jul; 24(13):2892-6. PubMed ID: 24835631 [TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of 11α-substituted bile acid derivatives as potential anti-tuberculosis agents. Pore VS; Divse JM; Charolkar CR; Nawale LU; Khedkar VM; Sarkar D Bioorg Med Chem Lett; 2015 Oct; 25(19):4185-90. PubMed ID: 26299346 [TBL] [Abstract][Full Text] [Related]
16. Synthesis, crystal studies, anti-tuberculosis and cytotoxic studies of 1-[(2E)-3-phenylprop-2-enoyl]-1H-benzimidazole derivatives. Kalalbandi VK; Seetharamappa J; Katrahalli U; Bhat KG Eur J Med Chem; 2014 May; 79():194-202. PubMed ID: 24735645 [TBL] [Abstract][Full Text] [Related]
18. Efficient synthesis of new (R)-2-amino-1-butanol derived ureas, thioureas and acylthioureas and in vitro evaluation of their antimycobacterial activity. Dobrikov GM; Valcheva V; Nikolova Y; Ugrinova I; Pasheva E; Dimitrov V Eur J Med Chem; 2013 May; 63():468-73. PubMed ID: 23524112 [TBL] [Abstract][Full Text] [Related]
19. Discovery of novel phenoxyacetic acid derivatives as antimycobacterial agents. Ali MA; Shaharyar M Bioorg Med Chem; 2007 Mar; 15(5):1896-902. PubMed ID: 17251028 [TBL] [Abstract][Full Text] [Related]
20. Design and development of ((4-methoxyphenyl)carbamoyl) (5-(5-nitrothiophen-2-yl)-1,3,4-thiadiazol-2-yl)amide analogues as Mycobacterium tuberculosis ketol-acid reductoisomerase inhibitors. Krishna VS; Zheng S; Rekha EM; Nallangi R; Sai Prasad DV; George SE; Guddat LW; Sriram D Eur J Med Chem; 2020 May; 193():112178. PubMed ID: 32171154 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]